Document is current

Any future updates will be listed below

Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?

Crossref DOI link: https://doi.org/10.1007/s00280-015-2796-6

Published Online: 2015-06-13

Published Print: 2015-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark